| Range: | 27.79-46.8 | Vol Avg: | 45892 | Last Div: | 0.3 | Changes: | 0.8 |
| Beta: | 0.19 | Cap: | 19.85B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed Oct 04 2023 | Empoloyees: | 22633 | ||
| CUSIP: | CIK: | ISIN: | US7999261008 | Country: | CH | ||
| CEO: | Mr. Richard Saynor | Website: | https://www.sandoz.com | ||||
SDZNY 42.87 Stock Price Sandoz Group AG
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.
Stock Details
Positive 0.24
SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz G...
zacks.com·Mon Nov 18 2024
Positive 0.30
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Drugs sector have probably already heard...
zacks.com·Fri Nov 01 2024
Positive 0.38
Sandoz reports third-quarter and nine-month 2024 sales
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Str...
globenewswire.com·Wed Oct 30 2024
Positive 0.28
Sandoz Canada achieves carbon neutral certification for its commercial operations
BOUCHERVILLE, Quebec, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sandoz Canada obtained carbon neut...
globenewswire.com·Mon Oct 07 2024
Positive 0.34
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz G...
zacks.com·Mon Sep 30 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow